Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript

Outset Medical, Inc. (OM) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 12, 2026

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results

SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the fourth quarter and year ended December 31, 2025.

GlobeNewsWire • Feb 11, 2026

OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System

Outset Medical stock jumps after FDA clears next-gen Tablo dialysis system, the first to meet the agency's latest cybersecurity standards.

Zacks Investment Research • Jan 28, 2026

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability and connectivity for hospitals, health systems and home providers of dialysis.

GlobeNewsWire • Jan 27, 2026

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026

SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2025 after the close of trading on Wednesday, February 11, 2026.

GlobeNewsWire • Jan 26, 2026

Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Outset Medical, Inc. (OM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 15, 2026

Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?

Outset Medical (OM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks Investment Research • Jan 13, 2026

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, and named Karen N. Prange to its board of directors.

GlobeNewsWire • Jan 12, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM

NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PRNewsWire • Jan 8, 2026

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026, at 4:30 p.m. Pacific time.

GlobeNewsWire • Jan 5, 2026